Omeros reported $333K in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acelrx Pharmaceuticals ACRX:US $ 0.88M 0.09M
Adma Biologics ADMA:US $ 26.14M 0.7M
Aerie Pharmaceuticals AERI:US $ 3.74M 3.04M
Alnylam Pharmaceuticals ALNY:US $ 40.81M 5.18M
Biomarin Pharmaceutical BMRN:US $ 123.13M 6.16M
Dynavax Technologies DVAX:US $ 83.37M 43.41M
Gilead Sciences GILD:US $ 1442M 18M
Heron Therapeutics HRTX:US $ 16.18M 4.82M
Insmed INSM:US $ 16.4M 4.2M
Intercept Pharmaceuticals ICPT:US $ 0.31M 0.45M
Knight Therapeutics Inc GUD:CN C$ 37.52M 6.19M
MacroGenics MGNX:US 2.4M 2.35M
Pacira Pharmaceuticals PCRX:US $ 50.63M 14.55M
Pfizer PFE:US $ 8671M 1339M
Rockwell Medical RMTI:US $ 16.94M 0.03M
Sarepta Therapeutics SRPT:US $ 37.8M 6.35M
United Therapeutics UTHR:US $ 29.7M 3.8M
Vertex Pharmaceuticals VRTX:US $ 261.8M 16M